Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025Blood

Comprehensive DNA/RNA-based targeted sequencing for molecular karyotyping and clonality assessment in newly diagnosed multiple myeloma patients

View Full Paper
Ask AI
Bookmark
Share

Authors

NBNatalia BuenacheIVIria VázquezAOAlbert Oriol

Discussion

Loading...

Member takes

Overview

Evaluates next-generation sequencing and DNA analysis to improve risk stratification in multiple myeloma patients.

Key Points

  • This research aims to assess the utility of targeted sequencing for molecular karyotyping and clonality in multiple myeloma.
  • Analyzed bone marrow samples from 85 newly diagnosed multiple myeloma patients.
  • Employed next-generation sequencing to evaluate DNA and RNA for comprehensive profiling.
  • Performed bioinformatic analysis including differential expression and clonality assessment.
  • Next-generation sequencing revealed numerous mutations and translocations in multiple myeloma.
  • High accuracy in detecting cytogenetic alterations was achieved through this targeted approach.
  • Differential expression analysis identified gene clusters associated with survival outcomes.

Cite This Study

Buenache et al. (2025) studied this question.

synapsesocial.com/papers/69362f514fa91c937236d987https://doi.org/10.1182/blood-2025-2562
View Full Paper
Ask AI
Bookmark
Share